Tag: US

April 15, 2019 Off

United States Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Biosimilars Market, Dosage, Price & Clinical Pipeline Outlook 2025” report has been added to ResearchAndMarkets.com’s offering. “US…

February 28, 2017 Off

ASIT soon to discuss with US and German regulatory on further development and marketing its grass pollen product

By Dino Mustafić

ASIT biotech, a Belgian clinical-stage biopharmaceutical company could soon market its gp-ASIT+ grass pollen product, as it showed positive results in Phase III clinical trial in grass pollen rhinitis.